Puff Puff Post

NOVEMBER 5, 2019

. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. For more information, visit www.inmedpharma.com. About INM-755.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

Cannabis Law Report

AUGUST 10, 2021

This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. (“Shanti”), and all its assets focused on psychedelic MDMA-based drug development. from 2020 to 2030 and generate revenue of $151.7

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Cannabis Law Report

DECEMBER 2, 2021

–(BUSINESS WIRE)– #Alzheimers –(NYSE American: IGC), India Globalization Capital, Inc. IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. THC is a naturally occurring cannabinoid produced by the cannabis plant. POTOMAC, Md.–(BUSINESS

Clinical Trials 40

Clinical Trials Data Patients THC 40

Puff Puff Post

MARCH 10, 2020

InMed and CHDR are currently preparing the Clinical Trial Application for a second Phase 1 clinical trial (755-102-HV), planned to begin in the second quarter of 2020, which will examine the local safety of INM-755 on small areas of wounded skin in healthy volunteers. For more information, visit www.inmedpharma.com.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

JULY 26, 2021

OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, has appointed Praveen Tyle, Ph.D., SAN DIEGO, CA, July 26, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. About Skye Bioscience.

Research and Development 105

Research and Development Clinical Trials Pharmaceutical Cannabinoids 105

Cannabis Law Report

OCTOBER 6, 2021

Flora will conduct thorough due diligence and honor the traditional FDA and NHS route in scientific processes to ensure consistency, quality, and delivery of cannabinoids for specific disease conditions, backed by data, with an initial focus on fibromyalgia, brain health, pain, and related research. About Flora Growth Corp.

Clinical Trials 40

Clinical Trials Research and Development Pharmaceutical Events 40

Cannabis Law Report

JULY 28, 2021

The Company and Its Subsidiary KGK Science Have Also Completed the Pre-Qualification Audits of Its Canadian Facilities to Enable Clinical Trials in an Arrangement with Aleafia Health. The audits will enable KGK to conduct clinical trials in the areas of psychedelics and nutraceuticals, among other substances of study.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

Cannabis Law Report

JANUARY 4, 2022

& LOS ANGELES–(BUSINESS WIRE)– ANANDA Scientific Inc., (a Funding for this trial is from the National Institute on Drug Abuse (NIDA). Clinical Trials.gov Identifier: NCT03787628 ). GREENWOOD VILLAGE, Colo. & a biotech pharma company) today announced approval by the U.S.

Clinical Trials 40

Clinical Trials Treatment Research and Development Media 40

Cannabis Law Report

JULY 8, 2021

About Enveric Biosciences Enveric Biosciences is a patient-first biotechnology company developing rigorously tested, novel cannabinoid medicines to improve quality of life for cancer patients. ” This product is not approved for marketing anywhere in the world.

Treatment 98

Treatment Clinical Trials CBD Patients 98

Cannabis Law Report

NOVEMBER 12, 2021

AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. 11,141,404, titled “Formulations And Methods For Treating Acute Cannabinoid Overdose.” ” The patent provides protection through 2040 and describes use of the Company’s investigational drug ANEB-001 to treat acute cannabinoid overdose.

Pharmaceutical 52

Pharmaceutical Clinical Trials Business Research and Development 52

Cannabis Law Report

JULY 29, 2021

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

JANUARY 3, 2022

AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. Food and Drug Administration (FDA) during which the company received valuable guidance regarding the clinical development of ANEB-001 in the U.S. There is a large and growing need to treat acute cannabinoid intoxication with 1.7

Pharmaceutical 52

Pharmaceutical Cannabinoids Treatment Clinical Trials 52

Cannabis Law Report

JULY 27, 2021

–(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., plan to conduct a controlled clinical trial to further understand the effects of CBD in epilepsy treatment. Under the Leadership of Nicolas Schlienz, Ph.D., COLORADO SPRINGS, Colo.–(BUSINESS

Data 81

Data Epilepsy Research and Development Clinical Trials 81

Cannabis Law Report

JANUARY 10, 2022

DUBLIN–(BUSINESS WIRE)–The “U.S. Minor Cannabinoids Market Size, Share & Trends Analysis Report by Product (CBG, CBC, CBN, THCV, CBGA), by Application (Pain Management, Neurological Disorders), and Segment Forecasts, 2021-2028” report has been added to ResearchAndMarkets.com’s offering.

Cannabinoids 40

Cannabinoids Clinical Trials Research and Development Supply Chain 40

Cannabis Law Report

DECEMBER 23, 2021

DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. This report has been compiled to assist interested parties in understanding the market for the medical use of cannabinoids and where it may be heading. Companies Mentioned.

Pharmaceutical 74

Pharmaceutical Clinical Trials Research and Development Cannabinoids 74

Cannabis Law Report

SEPTEMBER 29, 2021

& LOS ANGELES–(BUSINESS WIRE)– ANANDA Scientific Inc. , ANANDA is a leading research-focused biotech company pioneering high-caliber clinical studies evaluating therapeutic targets for cannabinoids. GREENWOOD VILLAGE, Colo. & ABOUT ANANDA SCIENTIFIC.

Clinical Trials 40

Clinical Trials Medicine Treatment Research and Development 40

Cannabis Law Report

JUNE 30, 2021

LONDON–(BUSINESS WIRE)– Fourfive , the CBD and nutrition brand loved by athletes and those leading an active lifestyle, today called on the UK’s sports governing bodies to stop sitting if on the fence and conduct clinical trials into the effectiveness of CBD and medicinal cannabis in professional sport.

Medicine 75

Medicine Clinical Trials CBD Sleep 75

Cannabis Law Report

JULY 8, 2021

Seeks To Identify Novel Cannabinoids For Therapeutic Use. –(BUSINESS WIRE)–cbdMD, Inc. Following the execution of this work, cbdMD Therapeutics will perform the requisite toxicological studies with Ion Tox, a leading in vitro toxicology and ADME-PK testing company, to support the safety of the cannabinoids of interest.

Research and Development 85

Research and Development Pets Cannabinoids eCommerce 85

Cannabis Law Report

FEBRUARY 2, 2022

– Flora’s research division, Flora Pharma, files USPTO provisional patent application on a cannabinoid-based formula. – Flora seeks approval to take their patent-pending, cannabinoid-based product through clinical trials under an EUA from INVIMA (Colombian FDA).

Cannabinoids 40

Cannabinoids Clinical Trials Events Cultivation 40

Cannabis Law Report

JANUARY 6, 2022

AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, announces that management will present a company overview at the H.C. Contacts.

Pharmaceutical 52

Pharmaceutical Clinical Trials Cannabinoids Business 52

Cannabis Law Report

AUGUST 25, 2021

TORONTO–(BUSINESS WIRE)– $HUGE #RestoreFSD –FSD Pharma Inc. In addition, Lucid’s pipeline includes Lucid-201, a psychedelic drug candidate targeting mental health disorders, and it is also investigating certain cannabinoids. million) in FSD Pharma stock (the “ Transaction ”), as further described below.

Clinical Trials 85

Clinical Trials Research and Development Therapy Conditions 85

Cannabis Law Report

JULY 4, 2019

The programme aims to investigate mechanisms of action of cannabis-based medicinal products related to several clinical applications including pain and cancer, as well as characterise cannabis-based medicinal products in disease models with particular focus of chronic pain, spasticity and cancer.

Cannabinoids 40

Cannabinoids Clinical Trials Chronic Pain Medicine 40

Veriheal

AUGUST 31, 2020

Add onto that the difficulty of these unprecedented times, as a minority-owned business, we’re making it our priority to pay it forward and invest in the future leaders of cannabis who will break barriers and pave the way for innovation in this burgeoning industry. . About Clinton: Clinton is an undergraduate student studying business.

Research and Development 119

Research and Development Education Agriculture Patients 119

Cannabis Law Report

JANUARY 27, 2022

DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Fragile X Syndrome” report has been added to ResearchAndMarkets.com’s offering. The majority of industry-sponsored drugs in active clinical development for FXS are in Phase II, with two drugs in Phase III. CLINICAL TRIAL LANDSCAPE. BIBLIOGRAPHY.

Clinical Trials 40

Clinical Trials Therapy Cannabinoids Topical 40

Cannabis Law Report

JANUARY 4, 2022

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Since March 2019, Mr. Allen has served as Chief Business Officer of Ambrx Biopharma Inc. Simon is a tremendous leader with significant commercial and business development experience, which are the most relevant skills for Anebulo at this stage.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Cannabinoids 52

Cannabis Law Report

JUNE 4, 2021

Dr. Titus has been involved in the development and investment of several industry-leading cannabis and industrial hemp businesses during his most recent career. A graduate of Rollins College in Winter Park, Florida, Titus majored in economics and minored in business administration. for CS First Boston Corp.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Cannabis Law Report

SEPTEMBER 14, 2021

A lack of consumer trust, transparency and scientific rigor has hampered the CBD and cannabinoid industry from reaching its growth potential for far too long”.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

OCTOBER 5, 2021

AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance addiction. Anebulo Pharmaceuticals, Inc. For further information about Anebulo, please visit www.anebulo.com.

Pharmaceutical 40

Pharmaceutical Clinical Trials Cannabinoids Events 40

Cannabis Law Report

JUNE 15, 2021

VANCOUVER, British Columbia–(BUSINESS WIRE)– Brains Bioceutical Corp. This landmark investment and strategic transaction solidifies Brains’ position as one of the leading pharmaceutical companies in the cannabinoid (CBD) sector. Brains” or the “Company”) is pleased to announce the completion of a USD $31.9

Pharmaceutical 63

Pharmaceutical Clinical Trials Research and Development Events 63

Cannabis Law Report

JUNE 15, 2022

ZenPharm, ASG Pharma and Panaxia Pharmaceutical MPXI are already licensed for their business in Malta. Malta is an ideal testbed for research given its small size and business-friendly approach. Clinical trials, etc. Malta Enterprise also supports human resources training.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Packaging 52

Cannabis Law Report

JANUARY 11, 2022

DENVER–(BUSINESS WIRE)– Ripple , Colorado’s trusted cannabis edibles brand and pioneer of fast-acting and clinically proven technology, is leading the way in cannabis wellness with new Ripple Sleep QuickDissolves and Ripple Sleep QuickGummies. Our mission is to improve people’s lives through cannabinoids.

THC 40

THC Clinical Trials Research and Development Sleep 40

Cannabis Law Report

JANUARY 9, 2019

Tindall was helping turnaround a business using his decades of experience in financial services, and also coming to terms with the death of his own father, when he had an awakening as to what medicinal cannabis was capable of. Tindall also hope to commence the clinical trials with Vanuatu for diabetes treatment.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Cannabis Law Report

JANUARY 19, 2022

–(BUSINESS WIRE)– #IGC –India Globalization Capital, Inc. We look forward to his guidance in helping us bring new, THC-based investigational medications into FDA approved clinical trials. IGC), headquartered in Maryland, engages in the development of cannabinoid-based therapies for healthcare applications.

Clinical Trials 40

Clinical Trials Research and Development Education Therapy 40

Cannabis Law Report

JANUARY 6, 2022

AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, announced today that it has appointed Scott L. Anebulo Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Cannabinoids Programs 52

Cannabis Law Report

JULY 4, 2021

Cannabidiol or CBD is one of the most common cannabinoids found in cannabis. Clinical trials across the EU have also shown CBD oils and other hemp products to have a potential range of benefits. There are two different types of cannabinoid receptors in your body. What Is CBD? What is THC?

THC 81

THC CBD Legalization Oil 81

Cannabis Law Report

SEPTEMBER 22, 2021

New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. We believe that the new data we are revealing today is an extraordinary achievement in the field of pharmaceutical cannabinoids,” said Adam Kaplin, M.D.,

Pharmaceutical 40

Pharmaceutical Data CBD Clinical Trials 40

Cannabis Law Report

SEPTEMBER 1, 2019

He and his business partner, outspoken financier Shane Yeend, spruiked a 2500-person jobs bonanza and an $800 million industry for North Adelaide, when the area was in great need of economic stimulus. “We The clinical trials and the standard of production could lead the world.”. But not everyone agrees. “I

Clinical Trials 53

Clinical Trials Research and Development Medicine Cultivation 53